| Literature DB >> 34887267 |
Nilofar Dorani1,2, Miranda M Zhang1,2, Gopala K Rangan3,4, Lara Abu-Zarour1,2, Ho Ching Lau1,2, Alexandra Munt1,4, Ashley N Chandra1,4, Sayanthooran Saravanabavan1, Anna Rangan5, Jennifer Q J Zhang1,4, Martin Howell6, Annette Ty Wong1,4.
Abstract
INTRODUCTION: Excessive water intake is rarely associated with life-threatening hyponatraemia. The aim of this study was to determine the clinical characteristics and outcomes of hyponatraemia associated with excess water intake.Entities:
Keywords: adult psychiatry; general endocrinology; genitourinary medicine; nephrology; nutrition & dietetics
Mesh:
Substances:
Year: 2021 PMID: 34887267 PMCID: PMC8663108 DOI: 10.1136/bmjopen-2020-046539
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Population, intervention, comparator and outcome characteristics of the inclusion criteria
| Population | Adults with or without comorbid conditions with water intoxication |
| Intervention | Oral water intake |
| Comparator | No intervention |
| Outcomes | Clinical characteristics, volume of water intake, serum sodium levels, treatment and outcome |
| Setting | All |
| Study Design | Case reports, observational cohort studies or randomised controlled trials |
Figure 1PRISMA flow diagram outlining the literature selection process.
Characteristics of studies that met the inclusion criteria
| Study design | No of articles n (%) | No of patients N (%) |
| Case reports | 157 (88.7) | 219 (37.1) |
| Retrospective cohort studies | 10 (5.6) | 254 (43.1) |
| Prospective cohort studies | 5 (2.8) | 44 (7.5) |
| Case–control studies | 3 (1.7) | 36 (6.1) |
| Cross-sectional study | 1 (0.6) | 27 (4.6) |
| Prospective uncontrolled study | 1 (0.6) | 10 (1.7) |
| Total | 177 (100) | 590 (100) |
Risk of bias assessment
| Score | No of publications | Risk of bias |
| 1 | 0 | High |
| 2 | 5 | High |
| 3 | 20 | Medium |
| 4 | 53 | Medium |
| 5 | 40 | Medium |
| 6 | 15 | Low |
| 7 | 18 | Low |
| 8 | 26 | Low |
Summary of demographics, serum sodium and water intake volumes in the case reports/case series
| All | Mild hyponatraemia (130–134 mmol/L) | Moderate hyponatraemia (125–129 mmol/L) | Severe hyponatraemia (<125 mmol/L) | |
| Mean age (years) (95% CI)* | 46±16 (43.6 to 48.0) | 38±10 (30.3 to 45.0) | 41 (35 to 47) | 47 (45 to 49) |
| Male:female (%)† | 53:47 | 67: 17 | 62: 38 | 52:48 |
| Comorbidities (%) | ||||
| None | 31% (69/223) | 50% (5/10) | 44% (12/27) | 28% (52/186) |
| Medical condition | 15% (33/223) | 0% (0/10) | 11% (3/27) | 16% (30/186) |
| Psychiatric disorder | 52% (117/223) | 50% (5/10) | 41% (11/27) | 54% (101/186) |
| Both (medical +psychiatric) | 2% (4/223) | 0% (0/10) | 4% (1/27) | 2% (3/186) |
| Concomitant medications (%) | ||||
| Not reported | 31% (70/223) | 30% (3/10) | 44% (12/27) | 30% (55/186) |
| No medications | 23% (51/223) | 50% (5/10) | 26% (7/27) | 21% (39/186) |
| Associated with hyponatraemia | 41% (92/223) | 20% (2/10) | 30% (8/27) | 44% (82/186) |
| Not associated with hyponatraemia | 5% (10/223) | 0% (0/10) | 0% (0/27) | 5% (10/186) |
| Reason for water intake | ||||
| Exercise | 12% (27/223) | 50% (5/10) | 29.6% (8/27) | 8% (14/186) |
| Iatrogenic | 13% (29/223) | 0% (0/10) | 18.5% (5/27) | 13% (24/186) |
| Habitual/dipsogenic | 7% (15/223) | 0% (0/10) | 11.1% (3/27) | 6% (12/186) |
| Psychogenic | 55% (123/223) | 40% (4/10) | 33.3% (9/27) | 59% (110/186) |
| Multiple reasons | 2% (5/223) | 0% (0/10) | 3.7% (1/27) | 2% (4/186) |
| Other | 11% (24/223) | 10% (1/10) | 3.7% (1/27) | 12% (22/186) |
| Mean serum sodium (mmol/L) (95% CI) | 118 (116 to 118) | 132 (131 to 133) | 127 (126 to 127) | 114 (113 to 115) |
| Median water intake per day‡ (litres) (95% CI) | 8.0 (8.9 to 12.2) | 5.0 (−2.2 to 14.5) | 8.0 (5.3 to 9.7) | 9.0 (9.2 to 13.0) |
| Median water intake over 4-hour period (litres) (95% CI)§ | 5.3 (5.3 to 8.6) | 3.1 (−0.3 to 8.3) | 6.2 (3.3 to 9.1) | 7.5 (5.4 to 9.6) |
*Age was not reported in n=25 individuals.
†Gender was not reported in n=64 individuals.
‡Data are from n=76 case report/case series.
§Data are from n=49 case report/case series.
Figure 2Categorisation of cases according to underlying comorbidities, main reason for water intake and use of concomitant drugs associated with hyponatraemia (low Na+).
Figure 33D scatterplot box to group cases according to water intake (A: litres per day; B: litres over 4 hours), comorbidity and serum sodium. Dots are coloured according to comorbidity group (psychiatric condition, pink; no underlying health condition or none, orange; multiple conditions, blue; medical condition, green). 3D, three dimensions.
Clinical features, patterns of treatment and clinical outcomes of water intoxication
| % (no/total data available) | All | Mild hyponatraemia (130–134 mmol/L) | Moderate hyponatraemia (125–129 mmol/L) | Severe hyponatraemia (<125 mmol/L) |
| Clinical features | ||||
| Not reported | 4.5% (11/223) | 10% (1/10) | 15% (4/27) | 3.2% (6/186) |
| No symptoms | 2.7% (6/223) | 40% (4/10) | 4% (1/27) | 0.5% (1/186) |
| Mild | 4.9% (10/223) | 10% (1/10) | 7% (2/27) | 3.8% (7/186) |
| Moderate | 34.5 (77/223) | 40% (4/10) | 37% (10/27) | 33.9% (63/186) |
| Severe | 53.4% (119/223) | 0% (0/10) | 37% (10/27) | 58.6% (109/186) |
| Onset of clinical features | ||||
| Not known | 30% (67/223) | 0% (0/10) | 37% (10/27) | 30.7% (57/186) |
| No clinical features reported/asymptomatic | 3% (6/223) | 40% (4/10) | 4% (1/27) | 0.5% (1/186) |
| Acute (<48 hours) | 41% (92/223) | 30% (3/10) | 41% (11/27) | 41.9% (78/186) |
| Chronic (>48 hours) | 26% (58/223) | 40% (4/10) | 18% (5/27) | 26.9% (50/186) |
| Treatment types | ||||
| Not reported | 13% (28/223) | 30% (3/10) | 22% (6/27) | 10% (19/186) |
| Supportive Care | 41% (92/223) | 50% (5/10) | 48% (13/27) | 40% (74/186) |
| Isotonic saline | 18% (41/223) | 10% (1/10) | 15% (4/27) | 19% (36/186) |
| Hypertonic (3%) saline | 28% (62/223) | 10% (1/10) | 15% (4/27) | 31% (57/186) |
| Treatment complications | ||||
| None | 90% (200/223) | 100% (10/10) | 96% 26/27) | 88% (164/186) |
| Rhabdomyolysis | 7% (16/223) | 0% (0/10) | 4% (1/27) | 8% (15/186) |
| Osmotic demyelination | 3% (7/223) | 0% (0/10) | 0% (0/27) | 4% (7/186) |
| Outcomes | ||||
| Not reported | 9% (19/223) | 40% (4/10) | 18.5% (5/27) | 5% (10/186) |
| Recovered (partial/complete) | 78% (175/223) | 60% (6/10) | 77.8% (21/27) | 80% (148/186) |
| Death | 13% (29/223) | 0% (0/10) | 3.7% (1/27) | 15% (28/186) |
Figure 43D scatterplot box to group cases according to serum sodium, treatment type and severity of clinical presentation. Dots are coloured according to treatment type (hypertonic saline, red; isotonic saline, orange; other, pink or not reported, blue). 3D, three dimensions.
Figure 5Categorisation of cases according to underlying comorbidities, water intake (litres per day) and outcomes.